期刊文献+

高尿酸血症与瘦素的相关性分析 被引量:5

The relationship between hyperuricemia and Leptin
下载PDF
导出
摘要 目的:探讨瘦素(Leptin)水平与高尿酸血症相关关系。方法:从2007年1~7月新疆医科大学附属中医医院住院病人中筛选出400例为研究对象,其中高尿酸血症组190例,正常组为同期该院的无高尿酸血症及痛风、无血缘关系及年龄性别构成无差别者210例。分别检测一般身体指标及生化指标。通过现场问卷完成研究对象的一般情况、疾病史的调查,采用ELISA酶联免疫法检测血清Leptin水平。结果:高尿酸血症组血清尿酸(SUA),甘油三酯(TG),高密度脂蛋白(HDL-C)及体重、体质指数(BMI)与正常组相比差异均有统计学意义,其中除HDL-C外均为高尿酸血症组高于正常组(P<0.05),Leptin与收缩压(SBP)、舒张压(DBP)、BMI、SUA均呈正相关。结论:Leptin参与代谢紊乱的病理机制,与代谢综合征指标密切相关,可能是高尿酸血症、肥胖、血脂异常等代谢综合征的共同发病基础。 Objectives: To study the relationship between hyperuricemia and Leptin. Methods: The 400 samples were collected from January to July 2007 in the affiliated Chinese medicine hospital, divided them into two groups: hyperuvicemia group (190 cases), control group (210 cases), measured the indexes including height, body weight, BMI, blood pressure and analyze the SUA, TG, TC, HDL-C, LDL-C, VLDL-C, use ELISA to detect the serum Leptin. Results: The indexes of SUA, TG, body weight and BMI increased and HDL-C had decreasing trend between hyperuricemia and control group. There are correlation between Leptin and SBP, DBP and BMI. Conclusions: Leptin participate in metabolic disorder and correlated with some indexes of metabolism syndrome. Leptin may be a part in the cause of hyperuricemia, obesity and metabolic disorder.
出处 《新疆医科大学学报》 CAS 2009年第6期699-700,703,共3页 Journal of Xinjiang Medical University
关键词 高尿酸血症 LEPTIN 相关性 hyperuricemia Leptin relationship
  • 相关文献

参考文献5

二级参考文献59

  • 1殷苏燕,仇新霞,李艳,郑法雷.慢性肾衰病人血清瘦素水平的变化及其影响因素[J].中国血液净化,2002,1(3):25-29. 被引量:1
  • 2[1]Scheen AJ. Pathophysiology of type 2 diabetes [ J]. Acta Clin Belg, 2003; 58(6): 335-41
  • 3[2]Takahashi M, Arita Y, Yamagata K. Genomic structure and mutations in adipose-specific gene, adiponectin[J]. Int J Obse, 2000; 24: 861- 8
  • 4[3]Saito K, Tobe T, Minoshima. Organization of the gene for gelatin-binding protein(GBP28) [J]. Gene, 1999; 229( 1 - 2): 67- 73
  • 5[4]Hare K, Boutin P, Mori Y. Genetic variation in the gene encoding adiponectin is associated risk of type 2 diabetes in the Japanese population[J]. Diabetes, 2002; 51(4): 1294
  • 6[5]Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T,Sumitsuji S, et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease[J]. J Am Coll Cardiol, 2004; 43(7): 1195-200
  • 7[6]Vasseur F, Helbecque N, Dina C. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipoctye-secreted adiponectin hormone levels and contributes to the genetic risk for type 2 diabetes in French Caucasians[J]. Hum Mol Genet, 2002; 11(21):2607 - 14
  • 8[7]Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al. Adiponectin acts in the brain to decrease body weight[J]. Nat Med, 2004; 10(5): 524- 9
  • 9[8]Furukawa K, Hori M, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, et al. Adiponectin down-regulates acylcoenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages[J]. Biochem Biophys Res Commun, 2004; 317(3): 831 - 6
  • 10[9]Maruyoshi H, Kojima S, Funahashi T, Miyamoto S, Hokamaki J, Soejima H, et al. Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina[J]. Thromb Haemost, 2004; 91(5): 1026-30

共引文献39

同被引文献55

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部